Tsu‐Han Lin
- Cardiology and Cardiovascular Medicine top 5%
- Molecular Biology
- Oncology
- Endocrinology, Diabetes and Metabolism top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- William P. DoleR. SarangapaniAdele NoèGary M. KsanderMonica Ligueros‐SaylanSuliman Al‐FayoumiJessie GuArco Y. Jeng
- Topics
- Drug Transport and Resistance Mechanisms (7 papers)Drug Solubulity and Delivery Systems (3 papers)Chronic Lymphocytic Leukemia Research (2 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Tsu‐Han Lin
20 papers receiving 739 citations
Peers
Comparison fields: 5 of 78
- Cardiology and Cardiovascular Medicine 371
- Molecular Biology 149
- Oncology 130
- Endocrinology, Diabetes and Metabolism 121
- Pulmonary and Respiratory Medicine 103
Countries citing papers authored by Tsu‐Han Lin
This map shows the geographic impact of Tsu‐Han Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsu‐Han Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsu‐Han Lin more than expected).
Fields of papers citing papers by Tsu‐Han Lin
This network shows the impact of papers produced by Tsu‐Han Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsu‐Han Lin. The network helps show where Tsu‐Han Lin may publish in the future.
Co-authorship network of co-authors of Tsu‐Han Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Tsu‐Han Lin. A scholar is included among the top collaborators of Tsu‐Han Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsu‐Han Lin. Tsu‐Han Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 8 | |
| 3 | 3 | |
| 4 | 14 | |
| 5 | 6 | |
| 6 | 29 | |
| 7 | 20 | |
| 8 | 46 | |
| 9 | 21 | |
| 10 | 2 | |
| 11 | 33 | |
| 12 | 406 | |
| 13 | 29 | |
| 14 | 37 | |
| 15 | 2 | |
| 16 | 37 | |
| 17 | 12 | |
| 18 | 6 | |
| 19 | 15 | |
| 20 | 7 |
About Tsu‐Han Lin
Tsu‐Han Lin is a scholar working on Pharmaceutical Science, Pharmacology and Oncology, having authored 20 papers that have together received 751 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Drug Solubulity and Delivery Systems (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (371 citations), Pharmaceutical Science (82 citations) and Pharmacology (75 citations). Tsu‐Han Lin has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include William P. Dole, R. Sarangapani, Adele Noè, Gary M. Ksander, Monica Ligueros‐Saylan, Suliman Al‐Fayoumi, Jessie Gu, Arco Y. Jeng, Handan He and Tycho Heimbach. Their work appears in journals such as Journal of Hepatology, Biochemical Pharmacology and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.